Carol Rockett

Carol Rockett, PharmD, RPh, CMPP, currently serves as Senior Director of Medical Affairs at Eisai US since December 2022. Previously held leadership roles at RedHill Biopharma Ltd. and BioCryst Pharmaceuticals, where responsibilities included directing global medical affairs teams and developing training materials. Carol Rockett's extensive experience at GSK spanned over two decades in various roles, including Marketing Director for Gene Therapy and Medical Director for North American Medical Affairs, notable for contributions to the launch of BENLYSTA, the first FDA-approved lupus treatment in 50 years. Early career experience includes serving as Clinical Pharmacy Coordinator at Duke University Medical Center and academic involvement as an associate professor. Carol Rockett earned a PharmD from the University of North Carolina at Chapel Hill and completed an Executive Education program at The Wharton School.